Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish
JournalAnnals of the Rheumatic Diseases
DOIs
Publication statusAccepted/In press - 2017 Dec 29

Fingerprint

Takayasu Arteritis
Giant Cell Arteritis
Safety
tocilizumab

Keywords

  • disease activity
  • giant cell arteritis
  • treatment

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

@article{e98b7d8007d94a4f929a4f9adec504ff,
title = "Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis",
keywords = "disease activity, giant cell arteritis, treatment",
author = "Lee, {Young Ho} and Song, {Gwan Gyu}",
year = "2017",
month = "12",
day = "29",
doi = "10.1136/annrheumdis-2017-212838",
language = "English",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis

AU - Lee, Young Ho

AU - Song, Gwan Gyu

PY - 2017/12/29

Y1 - 2017/12/29

KW - disease activity

KW - giant cell arteritis

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85048186035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048186035&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2017-212838

DO - 10.1136/annrheumdis-2017-212838

M3 - Article

C2 - 29288209

AN - SCOPUS:85048186035

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

ER -